StairMed completes China's first prospective clinical trial for invasive BMI with three successful implants

StairMed/Implanted BCI (Ultra-flexible Electrodes)

StairMed completed China's first prospective clinical trial for invasive brain-machine interfaces in collaboration with the Chinese Academy of Sciences and Fudan University's Huashan Hospital, with three successful implants performed in 2025. The trials demonstrated the safety and efficacy of the company's ultra-flexible electrode technology in human subjects.